Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 746

    2.

    Potent synergistic anti-human immunodeficiency virus (HIV) effects using combinations of the CCR5 inhibitor aplaviroc with other anti-HIV drugs.

    Nakata H, Steinberg SM, Koh Y, Maeda K, Takaoka Y, Tamamura H, Fujii N, Mitsuya H.

    Antimicrob Agents Chemother. 2008 Jun;52(6):2111-9. Epub 2008 Mar 31.

    PMID:
    18378711
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    3.

    Shift of clinical human immunodeficiency virus type 1 isolates from X4 to R5 and prevention of emergence of the syncytium-inducing phenotype by blockade of CXCR4.

    Esté JA, Cabrera C, Blanco J, Gutierrez A, Bridger G, Henson G, Clotet B, Schols D, De Clercq E.

    J Virol. 1999 Jul;73(7):5577-85.

    PMID:
    10364306
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    4.

    Palmitic Acid Is a Novel CD4 Fusion Inhibitor That Blocks HIV Entry and Infection.

    Lee DY, Lin X, Paskaleva EE, Liu Y, Puttamadappa SS, Thornber C, Drake JR, Habulin M, Shekhtman A, Canki M.

    AIDS Res Hum Retroviruses. 2009 Dec;25(12):1231-41.

    PMID:
    20001317
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    5.

    Evidence for a post-entry barrier to R5 HIV-1 infection of CD4 memory T cells.

    Vyakarnam A, Eyeson J, Teo I, Zuckerman M, Babaahmady K, Schuitemaker H, Shaunak S, Rostron T, Rowland-Jones S, Simmons G, Clapham P.

    AIDS. 2001 Sep 7;15(13):1613-26.

    PMID:
    11546935
    [PubMed - indexed for MEDLINE]
    6.

    Rapamycin reduces CCR5 density levels on CD4 T cells, and this effect results in potentiation of enfuvirtide (T-20) against R5 strains of human immunodeficiency virus type 1 in vitro.

    Heredia A, Gilliam B, Latinovic O, Le N, Bamba D, Devico A, Melikyan GB, Gallo RC, Redfield RR.

    Antimicrob Agents Chemother. 2007 Jul;51(7):2489-96. Epub 2007 May 7.

    PMID:
    17485501
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    8.

    Suppression of dualtropic human immunodeficiency virus type 1 by the CXCR4 antagonist AMD3100 is associated with efficiency of CXCR4 use and baseline virus composition.

    Fransen S, Bridger G, Whitcomb JM, Toma J, Stawiski E, Parkin N, Petropoulos CJ, Huang W.

    Antimicrob Agents Chemother. 2008 Jul;52(7):2608-15. Epub 2008 Apr 28.

    PMID:
    18443125
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    9.

    CCR5 density levels on primary CD4 T cells impact the replication and Enfuvirtide susceptibility of R5 HIV-1.

    Heredia A, Gilliam B, DeVico A, Le N, Bamba D, Flinko R, Lewis G, Gallo RC, Redfield RR.

    AIDS. 2007 Jun 19;21(10):1317-22.

    PMID:
    17545708
    [PubMed - indexed for MEDLINE]
    10.

    Role of CXCR4 in cell-cell fusion and infection of monocyte-derived macrophages by primary human immunodeficiency virus type 1 (HIV-1) strains: two distinct mechanisms of HIV-1 dual tropism.

    Yi Y, Isaacs SN, Williams DA, Frank I, Schols D, De Clercq E, Kolson DL, Collman RG.

    J Virol. 1999 Sep;73(9):7117-25.

    PMID:
    10438797
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    11.

    Differential effects of R5 and X4 human immunodeficiency virus type 1 infection on CD4+ cell proliferation and activation.

    Locher CP, Witt SA, Kassel R, Dowell NL, Fujimura S, Levy JA.

    J Gen Virol. 2005 Apr;86(Pt 4):1171-9.

    PMID:
    15784911
    [PubMed - indexed for MEDLINE]
    Free Article
    12.

    Complex determinants in human immunodeficiency virus type 1 envelope gp120 mediate CXCR4-dependent infection of macrophages.

    Ghaffari G, Tuttle DL, Briggs D, Burkhardt BR, Bhatt D, Andiman WA, Sleasman JW, Goodenow MM.

    J Virol. 2005 Nov;79(21):13250-61.

    PMID:
    16227248
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    14.

    HIV co-receptors as targets for antiviral therapy.

    Schols D.

    Curr Top Med Chem. 2004;4(9):883-93. Review.

    PMID:
    15134547
    [PubMed - indexed for MEDLINE]
    15.

    HIV-1 escape to CCR5 coreceptor antagonism through selection of CXCR4-using variants in vitro.

    Moncunill G, Armand-Ugón M, Pauls E, Clotet B, Esté JA.

    AIDS. 2008 Jan 2;22(1):23-31.

    PMID:
    18090388
    [PubMed - indexed for MEDLINE]
    16.

    HIV-1 dual/mixed tropic isolates show different genetic and phenotypic characteristics and response to maraviroc in vitro.

    Svicher V, Balestra E, Cento V, Sarmati L, Dori L, Vandenbroucke I, D'Arrigo R, Buonomini AR, Van Marck H, Surdo M, Saccomandi P, Mostmans W, Aerssens J, Aquaro S, Stuyver LJ, Andreoni M, Ceccherini-Silberstein F, Perno CF.

    Antiviral Res. 2011 Apr;90(1):42-53. Epub 2011 Feb 22.

    PMID:
    21349294
    [PubMed - indexed for MEDLINE]
    17.

    Inhibition of R5X4 dualtropic HIV-1 primary isolates by single chemokine co-receptor ligands.

    Ghezzi S, Menzo S, Brambilla A, Bordignon PP, Lorini AL, Clementi M, Poli G, Vicenzi E.

    Virology. 2001 Feb 15;280(2):253-61.

    PMID:
    11162839
    [PubMed - indexed for MEDLINE]
    18.

    Entry coreceptor use and fusion inhibitor T20 sensitivity of dual-tropic R5X4 HIV-1 in primary macrophage infection.

    Yi Y, Loftin L, Wang L, Ratcliffe SJ, Isaacman-Beck J, Collman RG.

    J Acquir Immune Defic Syndr. 2008 Mar 1;47(3):285-92.

    PMID:
    18197116
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    19.

    Generation and properties of a human immunodeficiency virus type 1 isolate resistant to the small molecule CCR5 inhibitor, SCH-417690 (SCH-D).

    Marozsan AJ, Kuhmann SE, Morgan T, Herrera C, Rivera-Troche E, Xu S, Baroudy BM, Strizki J, Moore JP.

    Virology. 2005 Jul 20;338(1):182-99.

    PMID:
    15935415
    [PubMed - indexed for MEDLINE]
    20.

    Reduced maximal inhibition in phenotypic susceptibility assays indicates that viral strains resistant to the CCR5 antagonist maraviroc utilize inhibitor-bound receptor for entry.

    Westby M, Smith-Burchnell C, Mori J, Lewis M, Mosley M, Stockdale M, Dorr P, Ciaramella G, Perros M.

    J Virol. 2007 Mar;81(5):2359-71. Epub 2006 Dec 20.

    PMID:
    17182681
    [PubMed - indexed for MEDLINE]
    Free PMC Article

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Write to the Help Desk